Immunotherapy and Existing Mental Health Conditions — Steroids, Mood and What Gets Monitored

A diagnosed mental health condition is not by itself a reason checkpoint inhibitor immunotherapy cannot be considered. It is treated as a planning question, not an exclusion. Your medical oncologist and the doctor who manages your mental health decide together, after looking at how stable you are now and what the treatment will actually ask of you.

That is not the answer most families expect. Depression, anxiety, bipolar disorder and psychotic illness still carry enough stigma in Indian medicine that patients often hide the diagnosis at the cancer consultation, or are told to sort that out first. Hiding it is the more dangerous option, because the part of immunotherapy that genuinely interacts with mental health is the part nobody warns you about.

That part is steroids. Immunotherapy itself is not a psychiatric drug. But when it causes a moderate or severe immune-related side effect, corticosteroids are the standard treatment for it, and corticosteroids can change mood, sleep and behaviour. In someone who already lives with a mental health condition, that is a real risk that deserves a plan made in advance.

There is a second, quieter overlap. Immunotherapy can affect the thyroid gland and the pituitary and adrenal glands. Those problems can look exactly like depression. If your team does not know your usual baseline, a treatable hormone problem can be filed away as low mood and left alone.

No page can tell you that you will be found eligible. That answer comes only from your own team reading your own reports. What this page can do is set out what they will look at, what changes if you go ahead, and which questions are worth asking out loud.

They can. Corticosteroids are the standard treatment for moderate and severe immune-related side effects of immunotherapy. Sleep loss, restlessness, irritability, elevated or low mood and, less often, confusion or psychosis are recognised effects of them. The risk is greater at higher doses and with longer courses.

Two things make this manageable rather than frightening. Steroids are not given routinely with every immunotherapy cycle — they are given if and when an immune-related side effect needs settling, so for many patients the question never becomes live. And when a course is needed, it is usually planned rather than sudden, which leaves room to warn you and your family first.

What turns it into a problem is silence. If your oncology team does not know you have a mental health condition, they cannot flag the risk before the first steroid dose, and your family cannot tell the difference between a bad week and a genuine change. The table below sets out the pattern to know about. It describes general NCCN and ASCO-aligned experience, not a prediction about you.

Usually yes. There is no routine requirement to stop antidepressants, mood stabilisers or antipsychotics before checkpoint inhibitor immunotherapy. Stopping them abruptly carries its own risk. Any change is made by the doctor who prescribes them, in discussion with your oncologist, and not by either team acting alone.

The failure mode here is not interaction. It is a handover that never happens — two teams each assuming the other is watching. These steps close that gap:

The decision is a multidisciplinary one, not a single doctor's verdict. Your medical oncologist brings the cancer plan. The doctor who manages your mental health brings your current stability, your medicines and your history. Where you want them there, the person who cares for you brings what daily life actually looks like. The output is a plan.

Four things carry most of the weight. How stable your mental health is right now, judged on the last few months rather than on the diagnosis label. Whether you can report symptoms reliably, or whether someone needs to be doing that with you. Whether the cycle schedule, the blood tests and the travel are realistic for your household. And what the alternatives are, including a different treatment, or not treating at all, where that is genuinely on the table.

An unstable period is not automatically a permanent no. More often it changes the sequence: stabilise first, then re-plan the cancer treatment with the mental health team already in the room. Ask for that reasoning out loud. The most useful question at the consultation is not am I eligible, but what specifically about my mental health would change your recommendation, and what would we do if it changed during treatment.

This is a framework for the conversation to have with your treating team. It is not a recommendation for or against immunotherapy in your case, and nothing here promises eligibility. Mental health care at CION is coordinated with your own prescriber or a mental health professional you are referred to, alongside the day-care immunotherapy given at our centres.

A recorded baseline before cycle one, then attention to change rather than to a single bad day. For someone with a mental health condition that baseline should include your usual mood, sleep and energy. Thyroid and hormone blood tests are part of standard immune-related side effect monitoring, and they matter here more than most people realise.

The reason is that new low mood on immunotherapy has several possible causes that look identical from outside. Treating all of them as psychological misses the treatable ones. Treating all of them as hormonal misses a genuine relapse. The table separates them.

Watch for change from their normal, not for a textbook symptom. The most useful clinical information a family gives is a comparison: sleeping less than usual, quieter than usual, more irritable than usual, since roughly this date. That is far more actionable than a good day or a bad day reported on its own.

A simple weekly note works better than memory. Sleep, appetite, mood and whether they are talking more or less than usual, written down with the date, and taken to the appointment. If a steroid course starts, note the date it started and the date the dose changed, because the timing is what tells the team whether the steroid is the likely cause.

Two boundaries are worth agreeing early. The first is what counts as an emergency, so nobody has to decide it under pressure: any thought of self-harm, new confusion, severe agitation, or seeing or hearing things that are not there goes to the emergency room the same day. The second is who calls whom for the non-urgent things, so it does not fall on the same exhausted person every time.

Caring for someone with both a cancer diagnosis and a mental health condition is genuinely heavy. Ask the team what support exists for you as well; it is a reasonable question and it is asked more often than you would think.

A mental health condition is rarely the only complicating factor in the room. If your cancer type is an uncommon one and the eligibility conversation has been vague for that reason too, Immunotherapy for Rare Cancers With No Standard Treatment explains how decisions get made when the guideline does not name your diagnosis. If you are living with a second cancer as well, Immunotherapy for Patients With a Second Cancer covers how two treatment plans are sequenced without either being ignored.

For a different eligibility question that turns on timing rather than stability, Immunotherapy During Pregnancy sets out what is known and what is not. And for how immunotherapy is delivered, dosed and monitored across our centres, start with Immunotherapy at CION Cancer Clinics.